Search

Your search keyword '"ANTIANDROGENS"' showing total 542 results
Start Over Descriptor "ANTIANDROGENS" Database Gale General OneFile
542 results on '"ANTIANDROGENS"'

2. Researchers at Shanghai Jiao Tong University School of Medicine Have Reported New Data on Cancer (Antiandrogen Treatment Induces Stromal Cell Reprogramming To Promote Castration Resistance In Cancer)

Subjects
Cell Press, Oncology, Experimental, Antiandrogens, Prostate cancer -- Development and progression -- Drug therapy, Cancer -- Development and progression -- Drug therapy -- Research, Periodical publishing, Physical fitness, Health
Abstract

2023 SEP 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Cancer. According to news reporting out of [...]

Published
2023

3. New Medical Science Study Findings Recently Were Published by Researchers at Faculty of Pharmaceutical Sciences in Sosnowiec (Application of Both Cluster and Principal Component Analysis for Evaluation of the Lipophilicity Parameters of ...)

Subjects
Antiandrogens, Physical fitness, Health
Abstract

2023 APR 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on medical science have been published. According to news [...]

Published
2023

6. Targeting FOXAI-mediated repression of TGF-[beta] signaling suppresses castration-resistant prostate cancer progression

Author

Song, Bing, Park, Su-Hong, Zhao, Jonathan C., Fong, Ka-Wing, Li, Shangze, Lee, Yongik, Yang, Yeqing A., Sridhar, Subhasree, Lu, Xiaodong, Abdulkadir, Sarki A., Vessella, Robert L., Morrissey, Colm, Kuzel, Timothy M., Catalona, William, Yang, Ximing, and Yu, Jindan

Subjects
Cellular signal transduction -- Research, Drug resistance -- Research, Enzalutamide -- Dosage and administration, Prostate cancer -- Development and progression -- Drug therapy, Transforming growth factors -- Research, Antiandrogens, DNA microarrays, Bone morphogenetic proteins, Occupancy, Stem cells, Tumors, Genes, Cancer metastasis, Transcription (Genetics), B cells, Health care industry
Abstract

Prostate cancer (PC) progressed to castration resistance (CRPC) is a fatal disease. CRPC tumors develop resistance to new-generation antiandrogen enzalutamide through lineage plasticity, characterized by epithelial-mesenchymal transition (EMT) and a basal-like phenotype. FOXA1 is a transcription factor essential for epithelial lineage differentiation. Here, we demonstrate that FOXA1 loss leads to remarkable upregulation of transforming growth factor beta 3 (TGFB3), which encodes a ligand of the TGF-[beta] pathway. Mechanistically, this is due to genomic occupancy of FOXA1 on an upstream enhancer of the TGFB3 gene to directly inhibit its transcription. Functionally, FOXA1 downregulation induces TGF-[beta] signaling, EMT, and cell motility, which is effectively blocked by the TGF-[beta] receptor I inhibitor galunisertib (LY2157299). Tissue microarray analysis confirmed reduced levels of FOXA1 protein and a concordant increase in TGF-[beta] signaling, indicated by SMAD2 phosphorylation, in CRPC as compared with primary tumors. Importantly, combinatorial LY2157299 treatment sensitized PC cells to enzalutamide, leading to synergistic effects in inhibiting cell invasion in vitro and xenograft CRPC tumor growth and metastasis in vivo. Therefore, our study establishes FOXA1 as an important regulator of lineage plasticity mediated in part by TGF-[beta] signaling, and supports a novel therapeutic strategy to control lineage switching and potentially extend clinical response to antiandrogen therapies., Introduction Prostate cancer (PC) is the third leading cause of cancer-related death among men in the United States, where 1 in 8 men are expected to be diagnosed with PC [...]

Published
2019
Full Text
View/download PDF

8. Polo-like kinase-1 Inhibitors and the Antiandrogen Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling

Subjects
Antiandrogens, Prostate cancer -- Development and progression -- Care and treatment, Androgens, Cancer -- Care and treatment -- Development and progression, Cancer cells, Physical fitness, Health
Abstract

2022 JUN 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained [...]

Published
2022

9. CHINA'S TRANSGENDER 'MEDICINE GIRLS' CAN'T FIND THE MEDICINE THEY NEED

Subjects
Antiandrogens, Transgender people, Drugs, Estrogen, News, opinion and commentary
Abstract

WASHINGTON, DC -- The following information was released by Radio Free Asia: For transgender women in China, transitioning can feel like a mythical quest, a fresh obstacle arising just after [...]

Published
2023

10. Complications of Androgen Deprivation Therapy in Men With Prostate Cancer

Author

Patil, Tejas and Bernard, Brandon

Subjects
Androgen suppression therapy -- Complications and side effects, Prostate cancer -- Care and treatment, Adverse drug reactions -- Care and treatment, Denosumab, Osteoporosis, Cancer patients, Gonadotropins, Androgens, Antineoplastic agents, Recurrence (Disease), Cancer metastasis, Health, Antiandrogens, Pamidronate, Menopause, Pituitary hormones, Zoledronic acid, Thromboembolism, Hormones, Sexual disorders, Biochemistry, Health
Abstract

The standard treatment for men with metastatic prostate cancer is androgen deprivation therapy (ADT). This therapy is associated with a multitude of side effects that can impact quality of life. These include vasomotor complications (in particular, hot flushes), sexual dysfunction and gynecomastia, osteoporosis, metabolic syndrome, and depression. Additionally, ADT has been associated with neurocognitive deficits, thromboembolic disease, and cardiovascular disease, although the data regarding the latter associations are mixed. This article summarizes the key side effects associated with ADT and discusses strategies to optimize management., Introduction Metastatic prostate cancer remains a global health challenge. Despite improvements in anticancer therapies, management of the disease is often a struggle to maintain a balance between preserving quality of [...]

Published
2018

11. Reports Summarize Prostate Cancer Study Results from Ankara University School of Medicine (Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same?)

Subjects
Oncology, Experimental, Antiandrogens, Cancer -- Research, Physical fitness, Health
Abstract

2021 APR 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on prostate cancer have been presented. According to news reporting [...]

Published
2021

13. Researchers from Inova Fairfax Hospital Detail New Studies and Findings in the Area of Prostate Cancer (Darolutamide for treatment of castration-resistant prostate cancer)

Subjects
United States. Food and Drug Administration, Physical fitness -- Research, Cancer research, Prostate cancer -- Drug therapy -- Research, Drug approval -- Research, Obesity, Antiandrogens, Editors, Health
Abstract

2020 MAY 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Prostate Cancer have been published. According [...]

Published
2020

14. New Cytochrome P450 17A1 Inhibitors Study Findings Have Been Reported from University of South Australia (Oral Formulation Strategies To Improve the Bioavailability and Mitigate the Food Effect of Abiraterone Acetate)

Subjects
Physical fitness -- Analysis -- Reports, Abiraterone -- Analysis -- Reports, Patient compliance -- Analysis -- Reports, Prostate cancer -- Drug therapy -- Analysis -- Reports, Acetates -- Analysis -- Reports, Obesity, Cancer treatment, Marketing, Antiandrogens, Finance, College football, Editors, Health, University of South Australia -- Reports, Zytiga (Medication) -- Reports
Abstract

2020 APR 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Drugs and Therapies - Cytochrome P450 17A1 Inhibitors are [...]

Published
2020

15. Data on Breast Pain Discussed by Researchers at Charite - University Medicine Berlin (Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO ...)

Subjects
Antiandrogens, Physical fitness, Prostate cancer -- Prevention -- Care and treatment, Pain management, Obesity, Radiation (Physics), Toxicity, Finance, Breast diseases, Editors, Diseases, Health
Abstract

2020 APR 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Breast Diseases and Conditions - Breast Pain have been [...]

Published
2020

16. Researchers at University of Rochester Medical Center Report Findings in Poly(ADP-Ribose) Polymerase Inhibitors (Olaparib and enzalutamide synergistically suppress HCC progression via the AR-mediated miR-146a-5p/BRCA1 signaling)

Subjects
Physical fitness -- Reports, Monosaccharides -- Reports, Medical centers -- Reports, Olaparib -- Research -- Reports, Enzalutamide -- Research -- Reports, Cancer research -- Reports, Anopheles, Carcinoma, Antiandrogens, Finance, Obesity, Hepatocellular carcinoma, Editors, Health
Abstract

2020 MAR 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Drugs and Therapies - Poly(ADP-Ribose) Polymerase Inhibitors is [...]

Published
2020

17. Data on COVID-19 Published by Researchers at Imperial College London (Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients)

Subjects
Antiandrogens, Severe acute respiratory syndrome, Coronaviruses, Business, Health, Health care industry, University of London. Imperial College of Science and Technology
Abstract

2023 JAN 15 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Current study results on COVID-19 have been published. According to [...]

Published
2023

18. Newer antiandrogens increase risk of depression in prostate cancer patients

Subjects
Oncology, Experimental, Antiandrogens, Prostate cancer -- Risk factors -- Care and treatment, Cancer patients -- Care and treatment, Depression, Mental -- Care and treatment -- Risk factors, Cancer -- Care and treatment -- Research, Pharmaceuticals and cosmetics industries, Health, Psychology and mental health
Abstract

Second-generation antiandrogen therapy is commonly used in the treatment of some forms of prostate cancer. The potency of these drugs carries an increased risk of adverse events, however, and recent [...]

Published
2022

19. Spain's secret service 'injected king with female hormones to slow sex drive'; The Spanish secret service injected Juan Carlos with female hormones as his sex drive was a danger to the state, a police chief has sensationally claimed

Subjects
United States. Secret Service, Antiandrogens, Sexual excitement, Hormones, Testosterone, General interest, News, opinion and commentary
Abstract

Byline: By, Leonie Chao-Fong Spain's former King Juan Carlos was injected with female hormones to control his sex drive as it was a danger to the state, a notorious police [...]

Published
2021

20. Researchers from Queen's University of Belfast Detail Findings in Cancer (The role of 5a-reductase inhibitors in gastro-oesophageal cancer risk: A nested case-control study)

Subjects
Physical fitness -- Health aspects -- Reports, Cancer research -- Health aspects -- Reports, Esophageal cancer -- Risk factors -- Research -- Health aspects -- Reports, Obesity, Hormones, Antiandrogens, Cancer metastasis, Editors, Sex hormones, Health
Abstract

2019 DEC 7 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Cancer is the subject of a report. According to [...]

Published
2019

21. Research Conducted at Queen's University Has Updated Our Knowledge about Cancer (The role of 5a-reductase inhibitors in gastro-oesophageal cancer risk: A nested case-control study)

Subjects
Physical fitness, Cancer research, Esophageal cancer -- Risk factors -- Research, Obesity, Hormones, Antiandrogens, Cancer metastasis, Editors, Sex hormones, Health
Abstract

2019 NOV 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Cancer. According to news originating from Belfast, [...]

Published
2019

22. Report Summarizes Antineoplastics Study Findings from University of Bologna (Radiotherapy Plus GnRH Analogue Versus High Dose Bicalutamide: A Case Control Study)

Subjects
Bicalutamide -- Research -- Reports, Luncheon meats -- Reports, Physical fitness -- Reports, Pituitary hormones -- Reports, Journalistic ethics -- Reports, Radiotherapy -- Reports, Prostate cancer -- Care and treatment -- Prognosis -- Research -- Reports, Adjuvant chemotherapy -- Reports, Gonadotropins, Hormones, Antineoplastic agents, Antiandrogens, Obesity, Glycoproteins, Editors, Cancer patients, Health, University of Bologna -- Reports
Abstract

2019 NOV 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Drugs and Therapies - Antineoplastics have been published. [...]

Published
2019

24. Study Results from University of Valencia in the Area of Prostate Cancer Reported (Frailty syndrome is associated with changes in peripheral inflammatory markers in prostate cancer patients undergoing androgen deprivation therapy)

Subjects
Elsevier Science Inc., Periodical publishing -- Research, Physical fitness -- Research, Fibrin -- Research, Cancer research, C-reactive protein -- Research, Fibrinogen -- Research, Tumor necrosis factor, Inflammation, Antiandrogens, Editors, Health
Abstract

2019 OCT 5 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Oncology - Prostate Cancer. According to news [...]

Published
2019

25. New Androgens Data Have Been Reported by Researchers at University of California (Structural Dynamics of Agonist and Antagonist Binding to the Androgen Receptor)

Subjects
Physical fitness, Testosterone, Hormones, Anopheles, Antiandrogens, Androgens, Medical law, Sex hormones, Genes, Obesity, Steroids (Organic compounds), Transcription (Genetics), Editors, Steroid hormones, Health, University of California
Abstract

2019 SEP 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Drugs and Therapies - Androgens have been published. [...]

Published
2019

26. Studies from University of Silesia Yield New Information about Antineoplastics (How Can We Improve the Physical Stability of Co-amorphous System Containing Flutamide and Bicalutamide? the Case of Ternary Amorphous Solid Dispersions)

Subjects
Bicalutamide, Physical fitness, Flutamide, Povidone, Prostate cancer, Obesity, Antineoplastic agents, Antiandrogens, Methyl methacrylate, Editors, Health
Abstract

2019 AUG 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Drugs and Therapies - Antineoplastics. According to [...]

Published
2019

27. Research Conducted at Louisiana State University Has Provided New Information about Phenothiazine Antipsychotics (Targeting the Tlk1/nek1 Ddr Axis With Thioridazine Suppresses Outgrowth of Androgen Independent Prostate Tumors)

Subjects
Physical fitness, Tumors -- Research, Prostate cancer -- Research, Thioridazine -- Research, Antipsychotic agents, Phenothiazines, Obesity, Cancer treatment, Cardiovascular diseases, Antiandrogens, Editors, Health, Louisiana State University
Abstract

2019 AUG 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Drugs and Therapies - Phenothiazine Antipsychotics. According [...]

Published
2019

28. Reports from Tongji University Describe Recent Advances in Prostate Cancer (Preclinical study using circular RNA 17 and micro RNA 181c-5p to suppress the enzalutamide-resistant prostate cancer progression)

Subjects
Physical fitness -- Reports, Enzalutamide -- Research -- Reports, Cancer research -- Reports, Prostate cancer -- Development and progression -- Research -- Reports, RNA -- Reports, Anopheles, Antiandrogens, Clinical trials, Medical research, Obesity, Endowments, Editors, Cancer patients, Health
Abstract

2019 JUL 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Oncology - Prostate Cancer is now available. According [...]

Published
2019

29. Studies from Laboratory of Growth Regulators Describe New Findings in Prostate Cancer (Tetrahydropyrazolo[1,5-a]pyridine-fused steroids and their in vitro biological evaluation in prostate cancer)

Subjects
Physical fitness -- Reports, Steroid hormones -- Reports, Cancer research -- Reports, Pyridine -- Reports, Prostate cancer -- Reports, Growth regulators -- Reports, Obesity, Hormones, Anopheles, Antiandrogens, Androgens, Editors, Health
Abstract

2019 JUN 29 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Oncology - Prostate Cancer are discussed in a new [...]

Published
2019

30. New Steroid Receptors Data Have Been Reported by Investigators at University of Clermont Auvergne (Ethanolic Extract of Algerian Propolis Decreases Androgen Receptor Transcriptional Activity In Cultured Lncap Cells)

Subjects
Physical fitness, Transcription (Genetics), Prostate cancer -- Genetic aspects, Proteins, Androgens, Obesity, Anopheles, Antiandrogens, Cancer metastasis, Tumors, Editors, Health
Abstract

2019 JUN 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Proteins - Steroid Receptors is the subject of a [...]

Published
2019

31. New Findings from Newcastle University in the Area of Prostate Cancer Reported (The Pioneering Role of GATA2 in Androgen Receptor Variant Regulation Is Controlled by Bromodomain and Extraterminal Proteins in Castrate-Resistant Prostate Cancer)

Subjects
Physical fitness, Prostate cancer, Androgens, Obesity, Antiandrogens, Medical research, Editors, Health, University of Newcastle upon Tyne
Abstract

2019 JUN 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Oncology - Prostate Cancer. According to news [...]

Published
2019

32. Reports on Prostate Cancer Findings from Dana-Farber Cancer Institute Provide New Insights (Bag1l: a Promising Therapeutic Target for Androgen Receptor-dependent Prostate Cancer)

Subjects
Cancer treatment -- Health aspects, Physical fitness -- Health aspects, Prostate cancer -- Health aspects, Androgens -- Health aspects, Obesity, Cancer research, Antiandrogens, Editors, Sex hormones, Health, Prostate Cancer Foundation
Abstract

2019 JUN 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Oncology - Prostate Cancer. According to news [...]

Published
2019

33. Data on Prostate Cancer Discussed by Researchers at Sichuan University (Discovery and Biological Evaluation of Novel Androgen Receptor Antagonist for Castration-resistant Prostate Cancer)

Subjects
Physical fitness -- Analysis, Enzalutamide -- Analysis, Abiraterone -- Analysis, Cancer research -- Analysis, Biochemistry -- Analysis, Prostate cancer -- Analysis, Obesity, Anopheles, Antiandrogens, Acetates, Cancer metastasis, Editors, Health
Abstract

2019 JUN 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Oncology - Prostate Cancer. According to news [...]

Published
2019

34. New Prostatectomy Findings from Department of Nuclear Medicine Outlined [The role of (68Ga)PSMA I&T in biochemical recurrence after radical prostatectomy: detection rate and the correlation between the level of PSA, Gleason score, and the SUVmax]

Subjects
Surgery, Physical fitness, Antigens, Obesity, Drugs, Sport utility vehicles, Antiandrogens, Tomography, Positron emission tomography, Editors, Health
Abstract

2019 MAY 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Surgery - Prostatectomy have been published. According to [...]

Published
2019

35. Essa Pharma presents new preclinical data for EPI-7386

Subjects
Enzalutamide, Prostate cancer, Antiandrogens, Tumors, Displays (Marketing), Business, News, opinion and commentary
Abstract

ESSA Pharma presented new preclinical data on ESSA's lead Investigational New Drug candidate at the 2019 American Urological Association Annual Meeting. The studies demonstrate that, pre-clinically, EPI-7386: Displays similar in [...]

Published
2019

36. ESSA Pharma nominates EPI-7386 as lead clinical candidate in metastatic CRPC

Subjects
Abiraterone, Cancer treatment, Prostate cancer, Cancer metastasis, Enzalutamide, Antiandrogens, Displays (Marketing), Pharmaceutical industry, Cancer, Androgens, Pharmaceuticals and cosmetics industries
Abstract

ESSA Pharma Inc, a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announced the nomination of EPI-7386 as the lead clinical candidate for the treatment [...]

Published
2019

37. Studies from University of Michigan Yield New Data on Obstetrics and Gynecology (Gender-affirming Hormone Therapy for Transgender Females)

Subjects
Estrogens -- Research, Obstetrics, Transgender people, Women's health, Antiandrogens, Women, Sex hormones, Editors, Health, Women's issues/gender studies, University of Michigan
Abstract

2019 MAR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Fresh data on Women's Health - Obstetrics and Gynecology are presented in a new [...]

Published
2019

38. Researchers from Northwestern University Report Findings in Prostate Cancer (Targeting Foxa1-mediated Repression of Tgf-beta Signaling Suppresses Castration-resistant Prostate Cancer Progression)

Subjects
Physical fitness -- Reports -- Physiological aspects, Prostate cancer -- Health aspects -- Reports, Bone morphogenetic proteins -- Reports -- Research, Enzalutamide -- Research -- Reports, Obesity, Antiandrogens, Cancer research, Stem cells, Tumors, Research funding, Transforming growth factors, Defense programs, Anopheles, Editors, Health
Abstract

2019 MAR 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Prostate Cancer have been published. According [...]

Published
2019

39. Recent Findings in Prostate Cancer Described by Researchers from Anhui Medical University (Targeting AR-Beclin 1 complex-modulated growth factor signaling increases the antiandrogen Enzalutamide sensitivity to better suppress the ...)

Subjects
Obesity, Antiandrogens, Cancer research, B cells, Physical fitness, Cancer patients, Editors, Health
Abstract

2019 FEB 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Oncology - Prostate Cancer. According to news [...]

Published
2019

40. Peking University First Hospital Reports Findings in Prostate Cancer (Androgen deprivation therapy in nonmetastatic prostate cancer patients: Indications, treatment effects, and new predictive biomarkers)

Subjects
Antiandrogens, Obesity, Cancer research, Cancer treatment, Biological markers, Cancer patients, Physical fitness, Antigens, Androgens, Tumors, Prostate cancer, Editors, Health
Abstract

2019 FEB 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Oncology - Prostate Cancer are presented in a new [...]

Published
2019

41. Researchers from University of California Discuss Findings in Prostate Cancer (Intra vs Inter Cross-Resistance Determines Treatment Sequence between Taxane and AR-Targeting Therapies in Advanced Prostate Cancer)

Subjects
Physical fitness -- Reports -- Health aspects, Abiraterone -- Research -- Reports -- Health aspects, Cancer research -- Reports -- Health aspects, Cancer treatment -- Reports -- Health aspects, Prostate cancer -- Research -- Care and treatment -- Reports -- Health aspects, Enzalutamide -- Research -- Reports -- Health aspects, Cabazitaxel -- Research -- Reports -- Health aspects, Antiandrogens, Obesity, Editors, Health
Abstract

2019 FEB 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Oncology - Prostate Cancer is now available. According [...]

Published
2019

42. Reports by A.C. Ferrari and Co-Researchers Describe Recent Advances in Prostate Cancer (Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer)

Subjects
Epigenetic inheritance -- Health aspects, Physical fitness -- Health aspects, Cancer research -- Health aspects, Cancer treatment -- Health aspects, Prostate cancer -- Care and treatment -- Health aspects, Panobinostat -- Health aspects, Bicalutamide -- Health aspects, Obesity, Antiandrogens, Tumors, Drug interactions, Editors, Health
Abstract

2019 FEB 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Oncology - Prostate Cancer. According to news [...]

Published
2019

43. Researchers at Ghent University Hospital Have Reported New Data on Biomarkers (Effects of Gender-Affirming Hormones on Lipid, Metabolic, and Cardiac Surrogate Blood Markers in Transgender Persons)

Subjects
Sex hormones -- Analysis, Transgender people -- Analysis, Biological markers -- Analysis, Women's health -- Analysis, Antiandrogens, Estrogens, Morbidity, Testosterone, Hormones, Editors, Health, Women's issues/gender studies
Abstract

2019 JAN 24 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Fresh data on Diagnostics and Screening - Biomarkers are presented in a new report. [...]

Published
2019

44. Concerns about transgender girls in sports are real

Subjects
Antiandrogens, Transgender people, Gay athletes, General interest, News, opinion and commentary
Abstract

Some people of the LGBTQ+ community have labeled Caitlyn (formerly Bruce) Jenner as a traitor to their movement, for Jenners public stand on disallowing transgendered females from competing in sports [...]

Published
2021

45. Dementia Risk Found to Vary by ADT Type

Subjects
Antiandrogens, Prostate cancer -- Risk factors, Medical schools, Alzheimer's disease -- Risk factors, Health
Abstract

DEMENTIA RISK associated with androgen deprivation therapy (ADT) for prostate cancer (PCa) depends on the type of ADT, according to investigators. In a study of 23,651 men with newly diagnosis [...]

Published
2020

46. Case series finds hair follicle miniaturization common

Author

Kilgore, Christine

Subjects
Antiandrogens, Minoxidil, Chemotherapy, Cancer -- Chemotherapy, Health, Health care industry
Abstract

Hair follicle miniaturization was a prominent feature of persistent chemotherapy-induced alopecia (pCLA) in breast cancer survivors who presented to four specialty hair clinics, and treatment with minoxidil (sometimes with antiandrogen [...]

Published
2021

47. Spironolactone use at discharge was associated with improved survival in hospitalized patients with systolic heart failure

Subjects
Cardiac patients -- Patient outcomes, Heart failure -- Patient outcomes, Hospital patients -- Patient outcomes, Antiandrogens, Spironolactone, Health
Abstract

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ahj.2010.08.036 Byline: Sanae Hamaguchi, Shintaro Kinugawa, Miyuki Tsuchihashi-Makaya, Kazutomo Goto, Daisuke Goto, Takashi Yokota, Satoshi Yamada, Hisashi Yokoshiki, Akira Takeshita, Hiroyuki Tsutsui Abstract: The RALES trial demonstrated that spironolactone improved the prognosis of patients with heart failure (HF). However, it is unknown whether the discharge use of spironolactone is associated with better long-term outcomes among hospitalized systolic HF patients in routine clinical practice. We examined the effects of spironolactone use at discharge on mortality and rehospitalization by comparing with outcomes in patients who did not receive spironolactone. Article History: Received 7 April 2010; Accepted 21 August 2010

Published
2010

48. Researchers from University of Colorado Describe Findings in Prostate Cancer (Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens)

Subjects
Cancer treatment, Antiandrogens, Physical fitness, Cancer research, Biochemistry, Prostate cancer -- Drug therapy, Androgens, Health, University of Colorado
Abstract

2018 NOV 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Oncology - Prostate Cancer. According to news [...]

Published
2018

50. Investigators from National Autonomous University of Mexico Zero in on Hormone Antagonists (Natural Steroids and Androgen Antagonists used as Neuroprotection in Common Neurological Disorders)

Subjects
Hormones, Antiandrogens, Physical fitness, Nervous system diseases, Health, National Autonomous University of Mexico
Abstract

2018 JAN 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Drugs and Therapies - Hormone Antagonists. According [...]

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results